AVNS FY2026 Revenue Growth
Resolves: AVNS's reported revenue for the fiscal year 2026 exceeds $1.1 billion.
sec_filing· Financial
AVNS FY2026 Revenue Growth
Market overview
Derived from AVANOS MEDICAL, INC. (AVNS) (CIK 0001606498) 10-K filing analysis
Financial prediction market
- Implied probability (Yes)
- 65%
- Closes
- 2027-02-24
About this prediction
Resolution criteria
AVNS's reported revenue for the fiscal year 2026 exceeds $1.1 billion.
More Financial markets
- AYTU BIOPHARMA, INC. Net Income Prediction — 75% Yes
- RTX Corp Revenue Growth — 75% Yes
- Net Operating Income (NOI) Growth — 60% Yes
- Stereotaxis, Inc. Operating Cash Flow Stability — 60% Yes
- GS Mortgage Securities Trust 2028-GSA3 - Continued Filing Compliance — 85% Yes
- Stereotaxis, Inc. Revenue Growth Projection — 75% Yes
- Net Written Premium Growth in 2026 — 75% Yes
- IMMR: Positive Net Income Projection — 75% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…